Meniere’s Disease – VJRegenMed
https://mirror.vjregenmed.com
The Video Journal of Regenerative MedicineFri, 28 Jan 2022 09:18:21 +0000en-US
hourly
1 https://wordpress.org/?v=6.5.2https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.pngMeniere’s Disease – VJRegenMed
https://mirror.vjregenmed.com
3232The potential of vesicular secretome fraction in hearing loss
https://mirror.vjregenmed.com/video/cysuxa7o6ay-the-potential-of-vesicular-secretome-fraction-in-hearing-loss/
Thu, 26 Aug 2021 14:05:30 +0000http://13.40.107.223/video/cysuxa7o6ay-the-potential-of-vesicular-secretome-fraction-in-hearing-loss/Eva Rohde, MD, Medical University Salzburg, Salzburg, Austria, describes ongoing research evaluating the therapeutic potential of the vesicular secretome fraction (VSF) in hearing loss. A single patient with Meniere’s disease, a condition of the inner ear, received a co-injection of VSF in one ear during surgical cochlear implantation, which resulted in a slight improvement in cochlear electrode function and no short- or long-term adverse events. The initiation of a Phase I safety clinical trial is pending, depending on the outcomes of ongoing pre-clinical safety testing, including biodistribution and toxicology assays. This interview took place during the International Society for Cell & Gene Therapy (ISCT) Annual Meeting 2021.
]]>